About: Peter H. Wiernik

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Peter H. Wiernik Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

member or fellow of the New York Academy of Medicine

Attributes	Values
rdf:type	Item
field of work	wds:Q100309276-E316C5FD-49D9-49BE-AB83-A41709799657
field of work	internal medicine
description	член Нью-Йоркської медичної академії (uk) member or fellow of the New York Academy of Medicine (en)
rdfs:label	Peter H. Wiernik (en) Peter H. Wiernik (nl)
skos:prefLabel	Peter H. Wiernik (en) Peter H. Wiernik (nl)
name	Peter H. Wiernik (en) Peter H. Wiernik (nl)
given name	wds:Q100309276-B90F0003-CDB3-46E1-BBFC-C21D86264EF8
given name	Peter
instance of	wds:Q100309276-475D67E2-CB15-4BD9-AF5D-93E8BF934E9B
instance of	Homo sapiens
award received	wds:Q100309276-BC239900-18DA-4611-B733-90EFBF1E7AED
award received	Fellow of the New York Academy of Medicine
skos:altLabel	Peter Wiernik (en) Peter H. Wiernik, MD (en)
sex or gender	wds:Q100309276-77A68451-7741-4E6D-9DC0-2143DB1DEF01
VIAF ID	wds:Q100309276-fdb853b3-a25b-452e-8341-7fe79f4c970f
IdRef ID	wds:Q100309276-C03BA5C6-6EC8-49B2-8E1E-4594F8DD6AF7
member of	wds:Q100309276-737FDFCB-1A46-4B28-93AC-0D3617F071D2
academic degree	wds:Q100309276-20910831-F873-4BA4-AEA0-227B2FEF998C
family name	wds:Q100309276-A381CF31-3FFB-45BB-8FDB-8EF342F628D1
National Library of Israel J9U ID	wds:Q100309276-7406961E-F83B-4369-BD78-38765EB465DA
VIAF ID	http://viaf.org/viaf/40696404
IdRef ID	http://www.idref.fr/059902523/id
sex or gender	male
VIAF ID	40696404
IdRef ID	059902523
member of	New York Academy of Medicine
academic degree	Doctor of Medicine
family name	Wiernik
National Library of Israel J9U ID	987007327970605171
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q100309276
is author of	A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia The TLX1 oncogene drives aneuploidy in T cell transformation Association of thyroid disease with acute leukemia Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid Cardiac monitoring of patients receiving arsenic trioxide therapy A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia Outcome of transplantation for myelofibrosis Hypersensitivity reactions from taxol Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. Factors affecting survival in nocardiosis Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung. Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study. Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies. Letter: Methicillin-associated thrombocytopenia Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Arterial embolism of tumor causing fatal organ infarction. Alloimmunization following prophylactic granulocyte transfusion Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998) Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. All-trans-retinoic acid in acute promyelocytic leukemia Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission FLT3 inhibitors for the treatment of acute myeloid leukemia. Capecitabine-induced pancolitis Taxol produces a predominantly sensory neuropathy Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Volume determinations in computed tomography. Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129 Adriamycin: A new effective agent in the therapy of disseminated sarcomas Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. Phase I clinical and pharmacokinetic study of taxol. Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Radiation-related pericarditis Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Extramedullary acute promyelocytic leukemia Complete remission in refractory anaplastic adult wilms' tumor treated with cisplatin and etoposide Review of amsacrine, an investigational antineoplastic agent. Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule Large and small fibre type sensory dysfunction in patients with cancer Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia Cost analysis of leukemia treatment: a problem-oriented approach

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software